Price T Rowe Associates Inc Quest Diagnostics Inc Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 7,194,697 shares of DGX stock, worth $986 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
7,194,697
Previous 5,984,238
20.23%
Holding current value
$986 Million
Previous $1.01 Billion
27.64%
% of portfolio
0.15%
Previous 0.12%
Shares
19 transactions
Others Institutions Holding DGX
# of Institutions
1,093Shares Held
107MCall Options Held
484KPut Options Held
626K-
Vanguard Group Inc Valley Forge, PA14.2MShares$1.95 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.18MShares$711 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY3.77MShares$517 Million0.04% of portfolio
-
Boston Partners Boston, MA3.04MShares$416 Million0.5% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...